Mode
Text Size
Log in / Sign up
N/A N=24 Randomized Triple-blind Treatment

Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory Hallucinations

Psychotic Disorders

Enrolled (actual)
24
Serious AEs
0.0%
Results posted
May 2026
Primary outcome: Primary: Auditory Hallucination Rating Scale (AHRS) — 30.00; 24.33; 26.82; 20.89 AHRS total score

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
DC Stimulator PLUS (NeuroConn) (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Bergen
Primary completion
Mar 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Auditory Hallucination Rating Scale (AHRS)
30.00; 24.33; 26.82; 20.89; 23.55; 21.56
PRIMARY
Hallucination Change Scale (HCS)
-24.9; -21.7
SECONDARY
Positive and Negative Syndrome Scale (PANSS)
18.45; 19.20; 17.82; 14.70; 18.36; 17.60
SECONDARY
Stroop Task
73; 77; 66; 63; 80; 69
SECONDARY
Trailmaking Test B
133; 93; 110; 82; 153; 86
SECONDARY
Apathy Evaluation Scale
47.55; 46.11; 51.82; 40.56; 52.45; 47.56
SECONDARY
The Clinical Global Impressions Scale - Severity
4.91; 4.56; 5.00; 4.44; 4.91; 4.44
SECONDARY
Global Assessment of Functioning - S
43.27; 46.22; 42.91; 45.44; 42.55; 44.00
SECONDARY
Dichotic Listening Paradigm
19.63; 25.83; 20.37; 22.5; 16.67; 22.5
SECONDARY
Dichotic Listening Laterality Index
-14.66; -0.45; -1.45; 9.15; 22.86; 7.58

Summary

The present study aims to investigate whether transcranial direct current stimulation (tDCS) reduces auditory hallucinations in patients with psychosis. In addition, the neuronal changes of tDCS will be examined.

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with schizophrenia spectrum disorder or other psychotic disorder
  • Frequent auditory hallucinations (at least 5 times a week).
  • Patients are on a stable dose of antipsychotic medication (which can also be zero) for at least 2 weeks.
  • Mentally competent for informed consent.
  • Provided informed consent.

Exclusion Criteria

  • Metal objects in or around the head that cannot be removed (i.e. cochlear implant, surgical clips, piercing)
  • History of seizures, or a history of seizures in first-degree relatives.
  • History of eye trauma with a metal object or professional metal workers
  • History of brain surgery, brain infarction, head trauma, cerebrovascular accident, broken skull, brain tumour, heart disease, cardiac pacemaker.
  • Skin disease on the scalp on the position of the tDCS electrodes
  • Coercive treatment based on a judicial ruling
  • Pregnancy in female patients
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02769507). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search